All posts by: Michael Zand

About Michael Zand

Rituximab after autologous stem cell transplantation in mantle cell lymphoma patients prolongs survival – 2 Minute Medicine

Continue reading

2017-09-28 NEWS

2 Minute Medicine

Rituximab after autologous stem cell transplantation in mantle cell lymphoma patients prolongs survival
2 Minute Medicine
1. Patients with mantle cell lymphoma treated with autologous stem cell transplantation experienced greater overall, event-free, and progression-free survival when treated with rituximab maintenance therapy compared to patients not receiving
Adding Drug to Standard Care May Prolong Lymphoma SurvivalU.S. News & World Report

all 2 news articles »

Continue reading

2017-09-28 NEWS

Terre Haute Tribune Star

Rose-Hulman students engineering bacteria to signal critical vitamin deficiencies
Terre Haute Tribune Star
Photo by Rose-Hulman Institute of Technology/Bryan Cantwell Rose-Hulman junior biochemistry student Madison Muncie, from Brazil, concentrates on completing work on a part of the institute’s synthetic biology team’s latest project, which will be entered

Continue reading

2017-09-28 NEWS

Gears Of Biz

Team develops gene circuit design strategy to advance synthetic biology
Gears Of Biz
“With the increase of circuit complexity, the lack of predictive design guidelines has become a major challenge in realizing the potential of synthetic biology,” said Lu, who also is affiliated with the Carl R. Woese Institute for Genomic Biology and

Continue reading

2017-09-28 NEWS

OC woman to get life-saving stem cell transplant from sister after US gov’t grants temp stay
KABC-TV
An Orange County woman who was on the brink of death and denied her sister’s life-saving stem cells by the U.S. government will now be able to receive the treatment. (KABC). KABC. By David Ono. Wednesday, September 27, 2017 07:29PM. IRVINE, Calif.